1-20 of 62
David T Teachey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How I Treat Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma in Children

David T Teachey, David O'Connor
Blood blood.2019001557.
DOI: https://doi.org/10.1182/blood.2019001557
Published: 2019
Journal Articles

Glucocorticoids Paradoxically Induce Intrinsic Steroid Resistance through a STAT5-Mediated Survival Mechanism in T-Cell Acute Lymphoblastic Leukemia

Lauren K. Meyer, Benjamin Huang, MD, Ritu Roy, PhD, Aaron Hechmer, PhD, Anica Wandler, PhD, Cristina Delgado-Martin, PhD, Adam B. Olshen, PhD, Terzah M. Horton, MD PhD, David T Teachey, MD, Kevin M. Shannon, MD, Michelle L. Hermiston, MD PhD
Blood (2018) 132 (Supplement 1): 913.
DOI: https://doi.org/10.1182/blood-2018-99-119930
Published: 2018
Journal Articles

PRC2 Inactivation Induces Resistance to Chemotherapy-Induced Apoptosis By Upregulating the TRAP1 Mitochondrial Chaperone in T-ALL

Kimberly Bodaar, MD, Ingrid M. Aries, PhD MSc, Salmaan Karim, Triona Ni Chonghaile, PhD BSc, Melissa A. Burns, MD, Laura Hinze, Maren Pfirrmann, James Degar, Jack Landrigan, Sebastian Balbach, Sofie Peirs, PhD, Bjorn Menten, PhD, Kristen E. Stevenson, MS, Donna S Neuberg, ScD, Meenakshi Devidas, PhD, Mignon L. Loh, MD, Stephen P. Hunger, MD, David T Teachey, MD, Karen R. Rabin, MD PhD, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Brent Wood, MD PhD, Lewis B. Silverman, MD, Stephen E. Sallan, MD, Pieter Van Vlierberghe, PhD, Stuart H. Orkin, MD, Birgit Knoechel, MDPhD, Anthony Letai, MD PhD, Alejandro Gutierrez, MD
Blood (2018) 132 (Supplement 1): 889.
DOI: https://doi.org/10.1182/blood-2018-99-113518
Published: 2018
Journal Articles

Spare the Spleen in ALPS: It Is Not an Expendable Vestigial Organ

V. Koneti Rao, MD FRCPA, Elaine Kulm, Susan Price, Sharon Webster, BSN, Les Folio, MD, Gulbu Uzel, MD, David T Teachey, MD
Blood (2018) 132 (Supplement 1): 2435.
DOI: https://doi.org/10.1182/blood-2018-99-117394
Published: 2018
Journal Articles

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Amanda M. Li, MD, George E Hucks, Amanda M. Dinofia, MD, Alix E. Seif, MD, David T Teachey, MD, Diane Baniewicz, Colleen Callahan, Christina Fasano, Beth McBride, Vanessa Gonzalez, Farzana Nazimuddin, MS, David L. Porter, MD, Simon F Lacey, PhD BS, Carl H June, MD, Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD
Blood (2018) 132 (Supplement 1): 556.
DOI: https://doi.org/10.1182/blood-2018-99-112572
Published: 2018
Journal Articles

Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL)

Robert James Hayashi, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Meenakshi Devidas, PhD, Brent Wood, MD PhD, Michelle L. Hermiston, MD PhD, David T Teachey, MD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Megan S. Lim, MD,PhD, Catherine M. Bollard, MD, Thomas G. Gross, MD PhD
Blood (2018) 132 (Supplement 1): 1000.
DOI: https://doi.org/10.1182/blood-2018-99-113481
Published: 2018
Journal Articles

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

Brief Report
Karen L. Bride, Tiffaney L. Vincent, Soo-Yeon Im, Richard Aplenc, David M. Barrett, William L. Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P. Dunsmore, Tori Fuller, Tina Glisovic-Aplenc, Terzah M. Horton, Stephen P. Hunger, Mignon L. Loh, Shannon L. Maude, Elizabeth A. Raetz, Stuart S. Winter, Stephan A. Grupp, Michelle L. Hermiston, Brent L. Wood, David T. Teachey
Blood (2018) 131 (9): 995–999.
DOI: https://doi.org/10.1182/blood-2017-07-794214
Published: 2018
Includes: Supplemental data
Journal Articles

Durable Remissions with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in CAR-Naive and CAR-Exposed Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Shannon L Maude, MD PhD, George E Hucks, Colleen Callahan, Diane Baniewicz, Christina Fasano, Christine Barker, Susan R. Rheingold, MD, Richard Aplenc, MD, Amanda M. Dinofia, MD, Amanda Li, MD BSc, David T Teachey, MD, David M. Barrett, Jennifer Brogdon, PhD, Regina M Young, PhD, John Scholler, Katherine T Marcucci, PhD, Bruce L Levine, PhD, Noelle Frey, MD, David L Porter, MD, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Carl H June, MD, Stephan A Grupp, MD PhD
Blood (2017) 130 (Supplement 1): 1319.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1319.1319
Published: 2017
Journal Articles

Targetting CD38 in T Cell Acute Lymphoblastic Leukemia

Karen L. Bride, MD PhD, Tiffaney L. Vincent, Soo-Yeon Im, David M. Barrett, Michelle L. Hermiston, MD PhD, Terzah M. Horton, MD PhD, Mignon L. Loh, MD, Shannon L Maude, MD PhD, Stephan A Grupp, MD PhD, Brent Wood, MDPhD, David T Teachey, MD
Blood (2017) 130 (Supplement 1): 3888.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3888.3888
Published: 2017
Journal Articles

Management of Coagulopathy Associated with CTL019 CAR T-Cell Therapy

Jochen Büchner, MDPhD, Stephan A Grupp, MD PhD, Shannon L Maude, MD PhD, Hidefumi Hiramatsu, MD PhD, David T Teachey, MD, Patricia A Wood, MD PhD, Rakesh Awasthi, PhD, Lan Yi, PhD, Barbara De Moerloose, MD PhD
Blood (2017) 130 (Supplement 1): 1276.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1276.1276
Published: 2017
Journal Articles

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

Sarah K. Tasian, David T. Teachey, Yong Li, Feng Shen, Richard C. Harvey, I-Ming Chen, Theresa Ryan, Tiffaney L. Vincent, Cheryl L. Willman, Alexander E. Perl, Stephen P. Hunger, Mignon L. Loh, Martin Carroll, Stephan A. Grupp
Blood (2017) 129 (2): 177–187.
DOI: https://doi.org/10.1182/blood-2016-05-707653
Published: 2017
Includes: Supplemental data
Journal Articles

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Shannon L Maude, MD PhD, David M. Barrett, MD PhD, Susan R. Rheingold, MD, Richard Aplenc, MD PhD, David T Teachey, MD, Colleen Callahan, MSN, Diane Baniewicz, MSN, Claire White, BSN, Mala K. Talekar, MD, Pamela A Shaw, PhD, Jennifer L Brogdon, PhD, Regina M Young, PhD, John Scholler, Katherine T. Marcucci, PhD, Bruce L Levine, PhD, Noelle Frey, MD MS, David L Porter, MD, Simon F. Lacey, PhD, J. Joseph Melenhorst, PhD, Carl H June, MD, Stephan A. Grupp, MD PhD
Blood (2016) 128 (22): 217.
DOI: https://doi.org/10.1182/blood.V128.22.217.217
Published: 2016
Journal Articles

Preclinical Development of a T-Cell ALL CAR Demonstrates That Differences in CAR Membrane Distribution May Impact Efficacy

Haneen Shalabi, DO, Haiying Qin, MS, Kelsey Wanhainen, BS, Jillian Smith, BS, Rimas Orentas, PhD, Nirali N Shah, MD, Shannon L Maude, MD PhD, Sarah K Tasian, MD, David T Teachey, MD, Javed Khan, MD, Terry J Fry, MD
Blood (2016) 128 (22): 4019.
DOI: https://doi.org/10.1182/blood.V128.22.4019.4019
Published: 2016
Journal Articles

CRLF2 Rearrangement Status in Ph-like ALL Predicts Intrinsic Glucocorticoid Resistance In Vitro that is Reversible with Targeted MAPK and PI3K Pathway Inhibition

Lauren K Meyer, Cristina Delgado-Martin, PhD, Shannon L Maude, MD PhD, David T Teachey, MD, Michelle L. Hermiston, MD PhD
Blood (2016) 128 (22): 910.
DOI: https://doi.org/10.1182/blood.V128.22.910.910
Published: 2016
Journal Articles

PRC2 Mutations Induce Resistance to Conventional Chemotherapy By Inhibiting Mitochondrial Apoptosis in T-Cell Acute Lymphoblastic Leukemia

Ingrid Ariës, PhD, Triona Ni Chonghaile, PhD, Salmaan Karim, Mina Jacob, Kristen E. Stevenson, MS, Donna S. Neuberg, ScD, Meenakshi Devidas, PhD, Mignon Loh, MD, Stephen Hunger, David T Teachey, MD, Karen R. Rabin, MD PhD, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Brent L. Wood, MD PhD, Lewis B. Silverman, MD, Stephen E. Sallan, MD, Birgit Knoechel, MD PhD, Pieter Van Vlierberghe, PhD, Anthony Letai, MD PhD, Alejandro Gutierrez, MD
Blood (2016) 128 (22): 604.
DOI: https://doi.org/10.1182/blood.V128.22.604.604
Published: 2016
Journal Articles

JAK/STAT Pathway Inhibition Reverts IL7-Induced Glucocorticoid Resistance in a Subset of Human T-Cell Acute Lymphoblastic Leukemia

Cristina Delgado-Martin, PhD, Kristin Shimano, MD, Matthew S Zinter, MD, Justin T. Wahlstrom, MD, Geoffrey A. Smith, Jack Taunton, PhD, Stuart S. Winter, MD, Justine E. Roderick, PhD, Michelle Kelliher, PhD, Terzah M. Horton, MD PhD, Brent L. Wood, MD PhD, David T Teachey, MD, Michelle L. Hermiston, MD PhD
Blood (2016) 128 (22): 3963.
DOI: https://doi.org/10.1182/blood.V128.22.3963.3963
Published: 2016
Journal Articles

Biomarker Profiling Differentiates Sepsis from Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

Simon F. Lacey, PhD, Pamela A Shaw, PhD, David T Teachey, MD, Scott L. Weiss, MD, Fang Chen, PhD, Vanessa E Gonzalez, M.B.A, Noelle Frey, MD MS, David L Porter, MD, Shannon L Maude, MD PhD, Stephan A Grupp, MD PhD, Edward Pequignot, M.S., Carl H June, MD, Jan J. Melenhorst, PhD
Blood (2016) 128 (22): 2812.
DOI: https://doi.org/10.1182/blood.V128.22.2812.2812
Published: 2016
Journal Articles

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial

Clinical Trials & Observations
Karen L. Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P. Lambert, Jack J. Bleesing, Alix E. Seif, Catherine S. Manno, James Casper, Stephan A. Grupp, David T. Teachey
Blood (2016) 127 (1): 17–28.
DOI: https://doi.org/10.1182/blood-2015-07-657981
Published: 2016
Includes: Supplemental data
Journal Articles

Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

David T Teachey, MD, Simon F. Lacey, PhD BSc, Pamela A Shaw, PhD, J Joseph Melenhorst, PhD, Noelle V. Frey, MD, Shannon L Maude, MD PhD, David M. Barrett, MD PhD, Richard Aplenc, MD PhD, Fang Chen, PhD, Julie Fitzgerald, MD PhD, Vanessa Gonzalez, M.B.A, Edward Pequignot, PhD, Susan R. Rheingold, MD, Scott Weiss, MD, Jason C. White, DO, Carl H. June, MD, David L. Porter, MD, Stephan A. Grupp, MD PhD
Blood (2015) 126 (23): 1334.
DOI: https://doi.org/10.1182/blood.V126.23.1334.1334
Published: 2015
Journal Articles

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela A Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MD PhD, Colleen Callahan, MSN, Simon F. Lacey, PhD BS, Bruce L. Levine, PhD, J Joseph Melenhorst, PhD, Laura Motley, RN, Susan R. Rheingold, MD, David T Teachey, MD, Patricia A. Wood, MD PhD, David Porter, MD, Carl H. June, MD
Blood (2015) 126 (23): 681.
DOI: https://doi.org/10.1182/blood.V126.23.681.681
Published: 2015